03.05.2013
- Gilead Sciences said on Thursday that its quarterly profit rose 63% as lower sales of its older HIV drugs were offset by strong sales of new products, but the results fell slightly...
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
27.02.2013
- GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...
16.01.2013
- Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...
28.11.2012
- Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked...
20.11.2012
- In A Clinch - Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient advocacy groups, investors, physicians and even other...
03.08.2012
- Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...
09.06.2012
- China has overhauled parts of its intellectual property laws to allow its drugmakers to make cheap copies of medicines still under patent protection in an initiative likely to...
